States Declare Emergencies As Biden Administration Names Monkeypox Management Team  

Updated

By Jefferey Jaxen

For those who lived through the opening rounds of the COVID response, there is a familiar feeling as states and cities begin to line up to declare state of emergencies for the monkeypox outbreaks. 

On Monday, both California Gov. Gavin Newsom and Illinois Gov. J.B. Pritzker declared states of emergency in their states. On the same day, New York Mayor Eric Adams followed suit in “a move that lets him suspend local laws and enact new rulesto better manage the city’s outbreak” reports Politico. 

Cities may also be acting in alignment with some states as the San Diego Union-Tribune reported, Nathan Fletcher, chair of the San Diego County Board of Supervisors, was quick to signal that “we are likely to align with the state in the coming days by making our own declaration.”

It has become common knowledge that the monkeypox virus is nothing like the coronavirus – both in transmissibility and mutation rate. The states of emergency declarations allow individual states to coordinate the distribution vaccines, prevention efforts and to raise awareness about the issue while working to align with whatever the federal response looks like.

To date, no emergency federal response has been declared yet the Biden Administration has picked Robert Fenton, a regional administrator for FEMA to serve as the White House monkeypox coordinator. Meanwhile, the director of the Division of H.I.V. Prevention at the Centers for Disease Control and Prevention, Dr. Demetre Daskalakis, will serve as his deputy.

With a primary focus on vaccinations, the nation’s eyes now look to Bavarian Nordic’s Jynneos vaccine for answers. The U.S. government has invested a whopping $1B over the last decade to bolster a stockpile of Jynneos vaccine for this exact scenario, so what do we know about its effectiveness? 

 In an August 1 article by MedpageToday, the title reads How Well Does the Monkeypox Vax Work? No One Knows for Sure. 

Media outlets are throwing around the number of 85% effectiveness. Yet as MedpageToday states, that number “is based entirely on a small study done in Africa in the 1980s that has major limitations. One data expert calls its findings “pretty weak.” Other studies have only been conducted in animals.”

There are two inconvenient facts emerging during these declared emergencies concerning America’s highly-prized, billion dollar vaccine investment.

First, a major concern was voiced at the WHO meeting last week by Unit Head of Global Infectious Hazards Preparedness at the WHO Tim Nguyen, when he stated: 

“I would like to underline one thing that is very important to WHO. We do have uncertainties around the effectiveness of these vaccines because they haven’t been used in this context and this scale before. And therefore, we are working with our member states, that when these vaccines are being delivered, that they are delivered in the context of clinical trial studies and prospectively collecting this data to increase our understanding on the effectiveness of these vaccines.” 

And second, in concurrence with Nguyen’s warning to the WHO, the CDC similarly states: “We do not know if JYNNEOS will fully protect against monkeypox virus infection in this outbreak. Individuals wanting to minimize their risk of infection should take additional preventive measures and self-isolate as soon as they develop monkeypox symptoms, such as a rash.”

While states step up prevention efforts and raise awareness to slow the spread of monkeypox, it seems like the Achilles’ heel, much like during the coronavirus outbreak, is the vaccine’s questionable effectiveness at stopping both transmission and infection.

The question on many people’s minds moving forward, after two years of societally-damaging lockdown restrictions imposed by public health officials and cheered on by experts in the media, is will they place restrictions on all of society in an attempt to slow the spread of monkeypox? 

Jefferey Jaxen

Jefferey Jaxen is a health journalist and featured in his weekly segment, ’The Jaxen Report’, on The HighWire. As an investigative journalist, researcher, and compelling writer, Jefferey serves as Lead editor of The HighWire News and Opinion Team.

Other Headlines

Coronavirus

Investigation Reveals Dangerous Bat Studies at CSU

The White Coat Waste Project uncovered 22 wasteful, dangerous bat studies funded by tax dollars and conducted in Colorado with ties to EcoHealth Alliance.  More details regarding Colorado State University’s (CSU) dangerous virus experiments on bats have been uncovered. The White Coat Waste Project (WCWP) revealed the details of 22 experiments. The experiments include Sars, CoV, Mers, Cedar, Nipah, and Sosuga viruses.  TheContinue reading Investigation Reveals Dangerous Bat Studies at CSU

More news about Coronavirus

Health & Nutrition

Study Shows 98% Of Children Grow Out of Gender Confusion by Adulthood

A new study concludes that 98% of gender-confused children grow out of it and will become comfortable with the gender that corresponds to their birth sex by the time they reach adulthood. The age with the highest rate of gender confusion is the age of 11, which is just before the typical onset of puberty.  TheContinue reading Study Shows 98% Of Children Grow Out of Gender Confusion by Adulthood

More news about Health & Nutrition

Vaccines

AstraZeneca Faces Landmark Lawsuit for COVID-19 Vaccine Trial Injury

A lawsuit, likely the first one of its kind, was brought against AstraZeneca for breach of contract for failing to pay the medical bills for the plaintiff injured in the COVID-19 vaccine clinical trial. Brianne Dressen was officially diagnosed with “Post Vaccine Neuropathy” by the National Institutes of Health (NIH). She has had substantial, debilitating injuries from her participation in the clinicalContinue reading AstraZeneca Faces Landmark Lawsuit for COVID-19 Vaccine Trial Injury

More news about Vaccines

Science & Tech

USDA Reopens Comment Period for Deregulation of Gene-Edited Plants

The deregulation of gene-edited plants is on the USDA agenda, and the public comment period has been extended by 21 days. The comment page has yet to be posted on the Federal Register. CRISPR is a new technology that is being used in agriculture to modify plants. “New Gene Technologies” or NGTs are how big agricultural companies like Bayer areContinue reading USDA Reopens Comment Period for Deregulation of Gene-Edited Plants

More news about Science & Tech

Environment

Unpacking the Global Health Security Strategy: Surveillance, Sustainability, and “One Health” Approach

President Joe Biden announced the release of a  U.S. Global Health Security Strategy (GHSS). The synopsis of the new plan states, “The new Global Health Security Strategy articulates a whole-of-government, science-based approach to strengthening global health security.” The plan is further explained as a necessary approach to mitigate harm from future pandemics while partnering with 50 countries.  In the aftermathContinue reading Unpacking the Global Health Security Strategy: Surveillance, Sustainability, and “One Health” Approach

More news about Environment

Policy

Boy Scouts of America Rebrands for Inclusivity: Introducing ‘Scouting America’

The Boy Scouts of America have announced they will change their name to Scouting America beginning in February 2025. The announcement has been described as a new inclusive name that is welcoming to everyone who may want to join. Last September, a Netflix documentary, “Scouts Honor: The Secret Files of the Boy Scouts of America,” detailedContinue reading Boy Scouts of America Rebrands for Inclusivity: Introducing ‘Scouting America’

More news about Policy